rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Astrana Health Inc.

ASTH · Nasdaq

IndustrialsProfessional ServicesJust started moving

ASTH stood above a rising 150-day average in 28 of the last 52 weekly readings, including each of the last 4 weeks. It is 0.6% above that average now. Professional Services: 36% of its 72 stocks in an uptrend (+1 points in four weeks); Industrials: 27% (−4 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
4 in a row
Industry in uptrend
36% +1 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
4
Institutions holding
192 (+38)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 28 of 52 weeks.

17 Apr – 16 Oct
23%34%44%Apr 26Jun 26Jul 26Sep 26Oct 26

Professional Services: A minority of its stocks are in an uptrend and the share has held steady. Industrials: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

4 disclosed lines: House 2, Senate 0, executive 2; 2 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k30 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k26 Feb 2026filed 14 May 2026
Judy Chu House: U.S. House ClerkCA28boughtspouse$100k–$250k19 Aug 2025filed 30 Aug 2025
Judy Chu House: U.S. House ClerkCA28soldspouse$100k–$250k19 Aug 2025filed 30 Aug 2025

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders192+38 on the quarter
New · exited57 · 18
Reported value$1.5B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20266,899,990$320.2M+736,263+11.9%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20262,605,775$120.9M+328,969+14.4%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,946,431$90.3M+236,169+13.8%
STATE STREET CORPadded · filed 7 Aug 20261,738,930$80.7M+88,440+5.4%
325 CAPITAL LLCreduced · filed 14 Aug 20261,613,843$74.9M-225,233−12.2%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20261,468,508$68.1M+100,429+7.3%
WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 20261,292,573$60.0M-49,251−3.7%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,167,974$54.2M+129,889+12.5%
BANK OF AMERICA CORPadded · filed 14 Aug 2026852,145$39.5M+277,416+48.3%
FMR LLCadded · filed 13 Aug 2026685,922$31.8M+269,797+64.8%
31 Mar 2023 – 30 Jun 2026
105147189Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

John Vong Company insiderSVP - Accounting (PAO) · last 10 Oct 20260 · 0
Brandon Sim Company insiderCEO and President · last 6 Oct 20265 · 0
Thomas S. Lam Company insiderDirector · last 6 Oct 20267 · 0
Chandan Basho Company insiderCOO and CFO · last 2 Oct 20260 · 0
Mitchell W. Kitayama Company insiderDirector · last 31 Aug 20260 · 0
David Schmidt Company insiderDirector · last 14 Aug 20260 · 1
Glenn Sobotka Company insiderOther · last 7 Aug 20260 · 0
John Chiang Company insiderDirector · last 10 Jun 20261 · 0
Linda Dong Company insiderDirector · last 10 Jun 20260 · 1
Matthew Mazdyasni Company insiderDirector · last 10 Jun 20260 · 0
Weili Dai Company insiderDirector · last 10 Jun 20260 · 0
Kenneth T. Sim Company insiderExecutive Chairman · last 6 Apr 202611 · 0

Same industry

HQI HireQuestLeading+31%
NEO NeoGenomicsLeading+28%
NSP InsperityLeading+26%
MG Mistras GroupLeading+20%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 20252.5%
Free cash flow marginFY 2025 · to 31 Dec 20253.3%
Return on capital employedFY 2025 · to 31 Dec 20254.9%
Cash conversionFY 2025 · to 31 Dec 2025510%
Debt to equityFY 2025 · to 31 Dec 20251.33×
Share count trendFY 2025 · to 5 Mar 202613.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$429.5M
Free cash flowFY 2025 · to 31 Dec 2025$104.5M

Analyst forecasts

No analyst forecasts yet.